BMY has been in the news 375% more than usual
Jan 07, 2026, 7:31 PM
-2.29%
What does BMY do
Bristol Myers Squibb Co., based in Princeton, NJ, employs 34,100 staff and develops biopharmaceuticals across various therapeutic classes, including oncology and immunology. Key products include Eliquis and Opdivo, with a strong pipeline featuring Krazati and KarXT.
BMY has been in the news recently: Bristol-Myers Squibb Company is a key player in the biotechnology and pharmaceutical industry, which is currently experiencing increased merger and acquisition activity, as seen with Amgen's acquisition of Dark Blue Therapeutics. Additionally, competitors like Pfizer are facing significant revenue challenges due to patent expirations, highlighting the competitive landscape within the sector.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.